Research ArticleClinical Studies

Serum Lactate Dehydrogenase Contributes to Prognostic Assessment in Patients With Oligometastatic Cancer and Brain Involvement

CARSTEN NIEDER, ASTRID DALHAUG and ADAM PAWINSKI
In Vivo January 2019, 33 (1) 229-232; DOI: https://doi.org/10.21873/invivo.11464

Article Information

vol. 33 no. 1 229-232
DOI 
https://doi.org/10.21873/invivo.11464
PMID 
30587628
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received October 30, 2018
  • Revision received November 12, 2018
  • Accepted November 13, 2018
  • Published online December 26, 2018.
Copyright & License 
Copyright © 2019 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. CARSTEN NIEDER1,2⇑,
  2. ASTRID DALHAUG1 and
  3. ADAM PAWINSKI1
  1. 1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
  2. 2Department of Clinical Medicine, Faculty of Health Sciences, UiT – The Arctic University of Norway, Tromsø, Norway
  1. Correspondence to: Dr. Carsten Nieder, Department of Oncology and Palliative Medicine, Nordland Hospital, 8092 Bodø, Norway. Tel: +47 75578449, Fax: +47 75534975, e-mail: carsten.nieder{at}nlsh.no
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Serum Lactate Dehydrogenase Contributes to Prognostic Assessment in Patients With Oligometastatic Cancer and Brain Involvement
CARSTEN NIEDER, ASTRID DALHAUG, ADAM PAWINSKI
In Vivo Jan 2019, 33 (1) 229-232; DOI: 10.21873/invivo.11464
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords